Teori Lock and Key dalam Enzim BiologiPelajari teori Lock and Key enzim biologi bagaimana enzim bekerja seperti kunci membuka ...

2. Kerja enzim juga dipengaruhi oleh inhibitor atau zat penghambat. ada dua macam inhibitor enzim, yaitu inhibitor kompetitif dan inhibitor nonkompetitif. Inhibitor kompetitif adalah inhibitor yang ...

Truqap, inhibitor ATP-kompetitif dari ketiga isoform AKT, sudah disetujui di AS, UE, Jepang, China, dan negara-negara lain untuk pasien dewasa tertentu dengan kanker payudara lanjut atau metastatik ...

Perusahaan menyoroti fokus OnKure pada onkologi presisi dan potensi keunggulannya dalam mengembangkan inhibitor PI3Kα yang ditargetkan ... dalam uji klinis dan posisinya di pasar onkologi yang ...

The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma (NPC) in adults. No trade name was indicated for the drug. The first ...

Hong Kong's Akeso has ended the week on a high note, with an FDA approval for its PD-1 inhibitor penpulimab and more data on PD-1/VEGF bispecific antibody ivonescimab. Penpulimab has picked up a ...

The two questions addressed in this “pragmatic” trial — whether adjunctive SGLT2 inhibitors are beneficial after TAVI and whether SGLT2 inhibitors are safe in older patients — were ...

NS-229 is an investigational selective Janus kinase 1 (JAK1) inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation. A global, randomized, double-blind ...

Use of a neoadjuvant checkpoint inhibitor enabled a high proportion of patients with early-stage mismatch repair-deficient (dMMR) solid tumors to avoid surgery and achieve organ preservation in a ...

Kinases are considered effective targets for drug development, especially with the notable success of kinase inhibitors in cancer treatment. Nonetheless, their capabilities in treating ...